USGBC Awards LEED Gold to Iroko Pharmaceuticals Navy Yard Headquarters
- Sep 12, 2013
The U.S. Green Building Council (USGBC) awarded a LEED Gold certification under the Core & Shell rating system to a state-of-the-art facility located at 150 Rouse Boulevard in Philadelphia’s Navy Yard Corporate Center, which represents one of the largest collections of energy-efficient commercial buildings in the Greater Philadelphia area. According to USGBC LEED rating systems, a LEED Certification for Core & Shell can be awarded to projects where the developer controls the design and construction process of the entire core and shell base building—all mechanical, electrical, plumbing and fire protection systems—but has no control over the tenant’s design and construction plans. Usually, these development projects include commercial or medical office buildings, retail centers, warehouses or research/lab facilities.
The 56,412-square-foot building was opened in December 2012 as the new global headquarters of Iroko Pharmaceuticals, LLC. A $15.4 million investment by Liberty Property Trust and Synterra Partners was designed by Philadelphia-based architecture firm DIGSAU and constructed by Penn Construction Company.
“The Iroko headquarters at 150 Rouse Boulevard is the ultimate expression of our vision and growth as a company,” said John Vavricka, President and CEO of Iroko Pharmaceuticals in a press statement. He added, “The sustainable building design and the open spaces represent our unlimited potential and reflect well on the spirit of our company.”
Iroko’s headquarters facility offers exterior views to 90 percent of regularly occupied building space, which means that employees can benefit from maximum daylight usage. Other sustainable amenities include high performance systems that manage energy, air and water quality, high-efficiency low-flow fixtures and secure bike racks and changing/shower facilities to promote the use of eco-friendly transportation.
The office building at 150 Rouse Boulevard is the seventh LEED-certified project developed by the Liberty Property/Synterra joint venture at the Philadelphia Navy Yard Corporate Center. The partnership recently announced an eighth sustainable office building, located at 201 Rouse Boulevard, which will break ground this month.
Rendering of Iroko Pharmaceuticals’ headquarters building courtesy of DIGSAU